Associated Papers
Single mutation tunes IRF4 function and mediates B cell character to ameliorate murine lupus.
Xiao ZX et al.
Iscience, 2025
Genetic, epigenetic, and molecular determinants of multiple myeloma and precursor plasma cell disorders: a pathophysiological overview.
Sutanto H et al.
Medical Oncology (northwood, London, England), 2025
Molecular basis for the functional roles of the multimorphic T95R mutation of IRF4 causing human autosomal dominant combined immunodeficiency.
Wang G et al.
Structure (london, England : 1993), 2023
Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC.
Sakthikumar S et al.
Veterinary and Comparative Oncology, 2023
Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma.
Ansari-Pour N et al.
Blood, 2023
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.
Rosa-Rosa JM et al.
Cancers, 2022
Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study.
Heestermans R et al.
Cancers, 2022
Circulating Tumor DNA: Less Invasive, More Representative Method to Unveil the Genomic Landscape of Newly Diagnosed Multiple Myeloma Than Bone Marrow Aspirates.
Liu Y et al.
Cancers, 2022
Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities.
Giesen N et al.
Haematologica, 2022
The molecular basis for the development of adult T-cell leukemia/lymphoma in patients with an IRF4K59R mutation.
Sundararaj S et al.
Protein Science : a Publication of the Protein Society, 2022
Structural determinants of the IRF4/DNA homodimeric complex.
Sundararaj S et al.
Nucleic Acids Research, 2021
Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.
Yasuda T et al.
Cancer Science, 2020
DNA-Repair Gene Mutations Are Highly Prevalent in Circulating Tumour DNA from Multiple Myeloma Patients.
Mithraprabhu S et al.
Cancers, 2019
Germline Risk Contribution to Genomic Instability in Multiple Myeloma.
Janz S et al.
Frontiers in Genetics, 2019
Progress in the identification of gene mutations involved in multiple myeloma.
Hu Y et al.
Oncotargets and Therapy, 2019
Mutations In Thirty Hotspot Genes In Newly Diagnosed Chinese Multiple Myeloma Patients.
Hu Y et al.
Oncotargets and Therapy, 2019
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
Bolli N et al.
Leukemia, 2018
An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia.
Cherian MA et al.
The Journal of Biological Chemistry, 2018
Monitoring multiple myeloma by quantification of recurrent mutations in serum.
Rustad EH et al.
Haematologica, 2017
Mutational landscape reflects the biological continuum of plasma cell dyscrasias.
Rossi A et al.
Blood Cancer Journal, 2017
Genomic complexity of multiple myeloma and its clinical implications.
Manier S et al.
Nature Reviews. Clinical Oncology, 2017
Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients.
Kortuem KM et al.
Blood Cancer Journal, 2016
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.
Walker BA et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2015
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.
Lohr JG et al.
Cancer Cell, 2014
Initial genome sequencing and analysis of multiple myeloma.
Chapman MA et al.
Nature, 2011
Comparison of Clinical Characteristics and Genetic Aberrations of Plasma Cell Disorders in Thailand Population.
Jirabanditsakul C et al.
Technology in Cancer Research & Treatment, 0